Literature DB >> 22024407

Effect of surfactant on 5-aminolevulinic acid uptake and PpIX generation in human cholangiocarcinoma cell.

Chung-Wook Chung1, Cy Hyun Kim, Kyung Ha Choi, Jin-Ju Yoo, Do Hyung Kim, Kyu-Don Chung, Young-Il Jeong, Dae Hwan Kang.   

Abstract

Photodynamic therapy (PDT) is a palliative therapy and has been used to cure cholangiocarcinoma (CC), which has a poor prognosis and limited available curative therapy. PDT was shown to improve the median survival time of advanced-stage patients. Recently, 5-aminolevulinic acid (ALA) has been used as a pro-photosensitizer, which can be transferred to intercellular protoporphyrin IX (PpIX), which is a strong photosensitizer, via the heme pathway. The main limitation of using ALA in PDT is the hydrophilic properties of ALA, which results in low cellular uptake. In this study, non-ionic surfactants, pluronic F68 (PF68) and Tween 80 (TW80), were used to address this limitation. The human CC cell line, HuCC-T1, was cotreated with ALA and different concentrations of surfactants for 4h. The effect of surfactants was evaluated by monitoring the uptake of ALA, the fluorescence intensity of PpIX, and the cell survival rate after suitable light irradiation. Cotreatment with the surfactant resulted in an increased intracellular ALA level, PpIX formation, and phototoxicity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024407     DOI: 10.1016/j.ejpb.2011.10.008

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Small molecule additive enhances cell uptake of 5-aminolevulinic acid and conversion to protoporphyrin IX.

Authors:  Kara M Harmatys; Anthony J Musso; Kasey J Clear; Bradley D Smith
Journal:  Photochem Photobiol Sci       Date:  2016-11-02       Impact factor: 3.982

2.  Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells.

Authors:  Cy Hyun Kim; Chung-Wook Chung; Hye Myeong Lee; Do Hyung Kim; Tae Won Kwak; Young-I L Jeong; Dae Hwan Kang
Journal:  Int J Nanomedicine       Date:  2013-06-12

3.  5-aminolevulinic acid-incorporated poly(vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy.

Authors:  Jin Ju Yoo; Chan Kim; Chung-Wook Chung; Young-Il Jeong; Dae Hwan Kang
Journal:  Int J Nanomedicine       Date:  2012-05-03

4.  In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.

Authors:  Lei Shi; Xiuli Wang; Feng Zhao; Hansen Luan; Qingfeng Tu; Zheng Huang; Hao Wang; Hongwei Wang
Journal:  Int J Nanomedicine       Date:  2013-07-24

5.  CD44 Receptor-Mediated/Reactive Oxygen Species-Sensitive Delivery of Nanophotosensitizers against Cervical Cancer Cells.

Authors:  Jieun Yoon; Howard Kim; Young-Il Jeong; Hoe Saeng Yang
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

6.  Reactive Oxygen Species-Sensitive Nanophotosensitizers of Methoxy Poly(ethylene glycol)-Chlorin e6/Phenyl Boronic Acid Pinacol Ester Conjugates Having Diselenide Linkages for Photodynamic Therapy of Cervical Cancer Cells.

Authors:  Ju-Il Yang; Hye-Lim Lee; Seon-Hee Choi; Jungsoo Kim; Young-Bob Yu; Young-Il Jeong; Dae-Hwan Kang
Journal:  Materials (Basel)       Date:  2021-12-25       Impact factor: 3.623

7.  Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma.

Authors:  Jie Ji; Zhixia Fan; Feifan Zhou; Xiaojie Wang; Lei Shi; Haiyan Zhang; Peiru Wang; Degang Yang; Linglin Zhang; Wei R Chen; Xiuli Wang
Journal:  Oncotarget       Date:  2015-07-10

8.  Hyaluronic Acid-Conjugated with Hyperbranched Chlorin e6 Using Disulfide Linkage and Its Nanophotosensitizer for Enhanced Photodynamic Therapy of Cancer Cells.

Authors:  Shin Jung; Seunggon Jung; Doo Man Kim; Sa-Hoe Lim; Yong Ho Shim; Hanjin Kwon; Do Hoon Kim; Chang-Min Lee; Byung Hoon Kim; Young-Il Jeong
Journal:  Materials (Basel)       Date:  2019-09-21       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.